Structural Formula (2a7745f5 4376 4a0a B040 Fdd441205d8d 01)
Buspirone Hydrochloride
Product Images NDC 50436-0182
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Buspirone Hydrochloride (NDC 50436-0182). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure (2a7745f5 4376 4a0a B040 Fdd441205d8d 02)
This text provides instructions for patients who have been prescribed either a 15mg or 30mg tablet by their doctor. The instructions detail how to take a smaller dose if necessary, by dividing the tablet into two or three parts. The text includes measurements for these smaller doses, for both the 15mg and 30mg tablets.*
Figure (2a7745f5 4376 4a0a B040 Fdd441205d8d 03)
Label Image (Lbl504360182)
This is a medication package for Buspirone Hydrochloride 15mg tablets manufactured by Cadia Healthcare Ltd. It contains 30 tablets and is stored at a controlled temperature not exceeding 25 degrees Celsius. Dosage information is provided in the package insert. The NDC number is 50436-0182-1 and the lot number is 300000C.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
